EPA:ALMKT - Euronext Paris - Matif - FR0010609263 - Common Stock - Currency: EUR
EPA:ALMKT (3/7/2025, 7:00:00 PM)
0.1756
+0 (+0.34%)
The current stock price of ALMKT.PA is 0.1756 EUR. In the past month the price increased by 1.86%. In the past year, price decreased by -58.92%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 29.15 | 217.38B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.5 | 28.81B |
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 65 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE FR
Employees: 68
Company Website: https://www.maunakeatech.com/
Investor Relations: https://www.maunakeatech.com/en/investors
Phone: 33148240345
The current stock price of ALMKT.PA is 0.1756 EUR. The price increased by 0.34% in the last trading session.
The exchange symbol of MAUNA KEA TECHNOLOGIES is ALMKT and it is listed on the Euronext Paris - Matif exchange.
ALMKT.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALMKT.PA and the average price target is 0.82 EUR. This implies a price increase of 364.69% is expected in the next year compared to the current price of 0.1756. Check the MAUNA KEA TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a market capitalization of 11.36M EUR. This makes ALMKT.PA a Nano Cap stock.
MAUNA KEA TECHNOLOGIES (ALMKT.PA) currently has 68 employees.
MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a support level at 0.16 and a resistance level at 0.19. Check the full technical report for a detailed analysis of ALMKT.PA support and resistance levels.
The Revenue of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is expected to decline by -20.42% in the next year. Check the estimates tab for more information on the ALMKT.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALMKT.PA does not pay a dividend.
MAUNA KEA TECHNOLOGIES (ALMKT.PA) will report earnings on 2025-04-24, after the market close.
MAUNA KEA TECHNOLOGIES (ALMKT.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
ChartMill assigns a technical rating of 2 / 10 to ALMKT.PA. When comparing the yearly performance of all stocks, ALMKT.PA is a bad performer in the overall market: 95.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA. ALMKT.PA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ALMKT.PA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 69.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -20.54% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 87% to ALMKT.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 56.52% and a revenue growth -20.42% for ALMKT.PA